Black Friday saleUp to 70% OFF

3mcompany

3M Company Is Back To Bullish Mode3M Company with ticker MMM was trading in a larger A-B-C correction within a higher degree wave IV for the last 5 years, but we have been warning about strong support with equal wavelength of waves A=C already back in 2023. As you can see now in 2024, we can see a strong rebound after a completed projected higher degree A-B-C correction within wave IV, so wave V can be now in play that can send the price back to all-time highs, especially if breaks channel resistance line and 175 level.
NYSE:MMMLong
by ew-forecast
MMM 3M Company Options Ahead of EarningsIf you haven`t bought MMM ahead of the previous earnings: Then analyzing the options chain and the chart patterns of MMM 3M Company prior to the earnings report this week, I would consider purchasing the 87usd strike price Calls with an expiration date of 2023-11-3, for a premium of approximately $2.39. If these options prove to be profitable prior to the earnings release, I would sell at least half of them. Looking forward to read your opinion about it.
NYSE:MMMLong
by TopgOptions
1
3M Company Is At Technical Support3M Company with ticker MMM has been trading bearish for the past 5 years, actually since the beginning of 2018, where we see a completed higher degree wave III. The wave structure from 2018 highs is in three waves A-B-C, which indicates for a higher degree wave IV correction. We can now see it sitting at interesting 90 support area, especially if we consider equal wave length of waves A=C that stopped at the former wave 3 swing high resistance around that 90 area. A recovery back above channel resistance line and 210 region would be definitely signal that higher degree wave V is in progress, which would send the price back to all-time highs.
NYSE:MMMLong
by ew-forecast
3M: I Want to Break Free 💪3M wants to break free from the compound consisting of the red zone between $93.83 and $107.35 and the green zone between $92.38 and $105.93, where it has finished wave (II) in white. To achieve this, the share has already developed convincing upwards momentum, which should soon carry it out of the zone-compound and above the resistance at $117.80. There, 3M should complete wave (3) in red before a counter movement should take it back below this mark. As soon as wave (4) is concluded, though, 3M should resume the overarching ascent. However, there is still a 33% chance that the share could lose its momentum and tumble below the support at $92.38. In that case, we would have to reckon with a new low in the form of wave alt.(II) in white first before a sustainable upwards movement can start.
NYSE:MMM
by MarketIntel
1
Analyzing the Good and Bad of 3M: Is It a Good Investment?When a company as renowned as 3M encounters difficulties, it's important to take a closer look at what's happening and why. While you may discover good news, there's also a chance you won't, but it's better to stay informed than to regret not paying attention. So, let's examine both the positive and negative aspects of 3M today. On the bright side, 3M has been increasing its dividend for more than six decades, making it one of the elite dividend kings. Additionally, the company's dividend yield of 5.8% is currently on the higher end of its historical range, which is a considerable draw for dividend investors. Moreover, with a consistent dividend growth rate of over 9% year-over-year for the past decade, it's easy to see why people might be interested in investing in the company's stock right now. In terms of traditional valuation metrics like price-to-earnings, price-to-sales, and price-to-book value, 3M remains an attractive investment option. All three metrics are hovering around their five-year averages, making the company a tempting investment opportunity. However, it's important to note that Wall Street rarely shorts stocks without a good reason. Dividends can also help provide insight into the company's performance. While the 10-year annual dividend growth rate for 3M is almost 10%, it's been declining in recent years. The average growth rate for the past five years has been just under 5%, with the average for the last three years being slightly over 1%. Furthermore, the most recent dividend increase was only 0.7%. This suggests that 3M's business has encountered adversity, and growth has slowed down. The most significant challenge 3M currently faces is legal and regulatory issues that won't be easily resolved. The most high-profile legal issue involves lawsuits related to earplugs sold to the military, with the company winning some cases and losing others. Recently, 3M has claimed that most of the plaintiffs aren't actually suffering from hearing loss. However, the lawsuit is expensive and likely to continue for some time. If 3M loses, the defeat could result in multi-billion dollar damages. Additionally, 3M is facing problems associated with producing "everlasting chemicals," which require costly efforts to clean up contaminated environments and may lead to years of litigation. The company plans to phase out production of these chemicals by 2025, which will result in expensive write-offs. This process will be challenging and costly. To make things even more complicated, 3M is planning to separate its medical business, which has long been viewed as a growth platform. Although this move may cause some concern, it would protect the business from liabilities that could impact the rest of the company's operations. Separating the medical business could also result in a higher price from Wall Street than if it were part of 3M. While this could be good news for shareholders, it does add complexity to the situation. Considering the long-term challenges 3M faces, it may not be a suitable investment for risk-averse investors due to the numerous company-specific concerns. However, it may make sense for more aggressive investors willing to take a bet on a company with an investment grade and a market capitalization of $50 billion, despite significant stock declines and legal and regulatory issues. Stocks don't enter the deep value zone for no reason, but investors must be prepared to weather the uncertainty if they decide to invest.
NYSE:MMMShort
by FOREXN1
3
MMM 3M Company 141K Calls, $200 Strike Price, Expiring Sept. 16!I don`t know if you monitored the Option Chain last Friday. I always do that for my clients and I was shocked to see for MMM 3M Company 141K Calls with $200 Strike Price, Expiring Sept. 16! On Thursday we had 70K calls, same expiration date and strike price. It has to do something with 3M's Healthcare Spinoff which sees Roadblock from Veterans, which sued the company to block its planned spinoff of the healthcare business. I bet the call options buyers are thinking that the spinoff will be approved in court by September 16. The stock is one of the Dividend Kings, the company has increased its dividend for 65 years and the Forward Dividend & Yield id 5.96 (4.90%). At this oversold level, with the RSI at 22, i wouldn`t be surprised to see at least a technical bounce to $130, if not even higher. Looking forward to read your opinion about it!
NYSE:MMMLong
by TopgOptions
2
3M Company (NYSE: $MMM) Trading Near Multi-Year Lows ⭐3M Company operates as a diversified technology company worldwide. It operates through four segments: Safety and Industrial; Transportation and Electronics; Health Care; and Consumer. The Safety and Industrial segment offers industrial abrasives and finishing for metalworking applications; autobody repair solutions; closure systems for personal hygiene products, masking, and packaging materials; electrical products and materials for construction and maintenance, power distribution, and electrical original equipment manufacturers; structural adhesives and tapes; respiratory, hearing, eye, and fall protection solutions; and natural and color-coated mineral granules for shingles. The Transportation and Electronics segment provides ceramic solutions; attachment tapes, films, sound, and temperature management for transportation vehicles; premium large format graphic films for advertising and fleet signage; light management films and electronics assembly solutions; packaging and interconnection solutions; and reflective signage for highway, and vehicle safety. The Healthcare segment offers food safety indicator solutions; health care procedure coding and reimbursement software; skin, wound care, and infection prevention products and solutions; dentistry and orthodontia solutions; and filtration and purification systems. The Consumer segment provides consumer bandages, braces, supports and consumer respirators; cleaning products for the home; retail abrasives, paint accessories, car care DIY products, picture hanging, and consumer air quality solutions; and stationery products. It offers its products through e-commerce and traditional wholesalers, retailers, jobbers, distributors, and dealers. The company was founded in 1902 and is based in St. Paul, Minnesota.
NYSE:MMMLong
by Bullishcharts
2
3M | Fundamental AnalysisThe continued poor performance of 3M stock indicates that investors are beginning to lose patience with the company. At the last investor presentation, management resigned from the full-year outlook it gave at the end of October. Thus, the company's stock is even falling out of favor with value-oriented investors and increasingly evolving an option only for dividend investors. Let's take a closer look at what's going on and whether 3M has investment potential. In early December, MMM CEO Mike Roman and CFO Monish Patolawala spoke at the Credit Suisse Industrial Companies Conference. They immediately told investors that organic sales growth in Q4 would be in the "lower half" of the expected growth range of zero to negative 2%. When a company lowers its sales estimates, it's never good news, but the update from 3M particularly disappointed investors. There are three reasons for this: First, the lower sales forecast came after management raised its full-year organic sales growth forecast in late October during its Q3 earnings presentation. In the third quarter, full-year organic sales growth was between 6% and 9%, but management noticed fit to increase the lower end of the range to 8%-9%, even as the full-year profit forecast was lowered to $9.70-$9.90 from $9.70 to $10.10. Considering that the assumed outlook for the fourth quarter has been lowered, investors are justifiably lowering earnings growth expectations. It also begs the question of why Patolawala decreased anticipations weeks after increasing them. Second, it's no secret that investors are watching 3M's margins closely for clues as to whether its restructuring measures are bringing operational improvements. Of course, it's much harder to judge this during a pandemic, but Patolawala has previously noted the significance of volume gain to 3M's margins. Given that sales growth will be weaker than expected, 3M's margins are likely to come under even more pressure in the fourth quarter. Third, management noted that it continues to experience supply shortages and high raw material costs. In other words, cost pressures will intensify in the fourth quarter. Consequently, 3M is seeking to raise prices so that the difference between price and raw material costs becomes margin neutral. At the conference, Patolawala was asked about pricing, to which he replied that investors should "wait and see" what prices 3M gets at the end of the quarter. The disappointing comments about pricing and the fact that 3M has not been able to offset rising costs with pricing actions call into question the company's business model and/or ability to execute it. For the record, 3M prides itself on investing heavily in research and development to produce differentiated products that have pricing power. Unfortunately, that pricing power is not apparent right now. Moreover, in recent years, company management has taken significant restructuring measures to improve performance. Indeed, during its third-quarter earnings call, Patolawala told investors that restructuring costs in 2021 would be between $300 million and $325 million, up from a previous forecast of $250 million to $300 million. Moreover, 3M management has restructured the business (business groups are now managed globally rather than by country) and the healthcare segment has been restructured through multibillion-dollar acquisitions and sales. So far, none of these restructuring actions has resulted in a noticeable improvement in growth or margins. Still, it's hard to be too critical of a company's management during a difficult trading period. In addition, Patolawala talked about the likelihood of improvements in volume growth, pricing, lower raw material costs, and the benefits of restructuring in the future. All of these factors point to higher margins in the future. In addition, 3M stock currently has a dividend yield of 3.5% and is well covered by free cash flow. Thus, the stock remains a good option for income-seeking investors. Finally, it relies on your investment profile. If you're looking for a relatively safe income source, 3M stock is a useful buy. However, poor operating performance and disappointing guidance will worry investors who prefer to see evidence of progress before buying. For those investors, it makes sense to wait and see what 3M reports in its subsequent earnings releases and what margin growth is projected for 2022.
NYSE:MMMLong
by FOREXN1
3
3M | Fundamental Analysis | Must Read...Industrial giant 3M will publish its Q3 earnings on Oct. 26. As always, quarterly earnings reports help shape investor thinking, whether it's near-term or long-term. Unfortunately, 3M management isn't likely to give investors much good news regarding near-term trends, but what about the long-term outlook? Here's what you should know before the earnings report comes out. The case for buying 3M is based on the idea that the significant free cash flow (FCF) generated by the company will give management the time and strength to turn around some of the volatile performance of recent years. Furthermore, based on that very FCF, the stock looks very favorable. If the company reaches Wall Street's consensus FCF forecast of $5.7 billion in 2021, it will trade at 18.2 times its FCF (current market capitalization is $104 billion). That's a pretty reasonable valuation for a mature industrial business proficient in increasing revenues at a rate not exceeding a single digit (in line with economic growth). If you add some margin expansion to this, and investors can expect a mix of stable earnings growth and dividend growth (current yield is 3.3%), then 3M is an excellent value investment option. However, the question is, where is 3M's profit margin headed? Gross profit margin (profit after cost of goods) is one of the best ways to measure a company's pricing power in the marketplace. While earnings margin before interest, taxes, depreciation, and amortization (EBITDA) also includes operating expenses and is a great way to measure how well a company is managed. 3M's performance has been questionable in recent years, and this is not due to the COVID-19 pandemic. In short, 3M needs to persuade investors that it can return the company to a long-term uptrend in margins. To that end, CEO Mike Roman restructured the business. The company is now managed from four operating segments rather than five, and business groups are now managed globally rather than by country. At the same time, management has undertaken restructuring expenses to streamline its operations. Moreover, management has invested in digital capabilities. The poorly performing healthcare segment has been restructured through divestitures and acquisitions, such as the $6.7 billion purchase of Acelity, a trauma business, and M*Modal, a $1 billion health information systems business; both deals were completed in 2019. So investors are right to sit back and say, "Show me margin expansion." But unfortunately, the COVID-19 pandemic has struck, and its distorting effects have made it much harder to see improvement, especially in terms of margin performance. Moreover, it is difficult to compare similar performance when the economy enters a period of downtime and resumption is impacted by soaring commodity prices and supply chain problems in key end markets. Moreover, many of the problems associated with resumption have worsened in 2021. As a result, the critical data most investors will be watching relates to the ratio of 3M's price to its cost of production. This is a critical metric for investors because 3M management prides itself on investing in innovation to produce differentiated products - in other words, products with pricing power. The dispute over whether 3M products are losing or gaining pricing power won't be resolved during the next earnings report, but we do know that pressure is building because of rising raw material costs and difficulties in the supply chain. For instance, CFO Monish Patolawala projected a $0 to $0.10 decline in earnings per share at the beginning of the year due to rising raw material prices. He later raised that forecast to $0.20, then to $0.30-$0.50 in April, and then to $0.65-$0.80 in July. Moving on to the Morgan Stanley Laguna Conference in mid-September, and Patolawala guided investors to the high end of the range. And that's without taking into account the impact on the supply chain of plant shutdowns during Hurricane Ida. Patolawala also said that inflation is outpacing 3M's ability to raise prices, and noted that auto production (a key end market for 3M) will be weaker than originally expected. In addition, the health care recovery has been uneven and the number of fee-for-service procedures is below management expectations, semiconductor shortages have impacted consumer electronics, and office resumption (3M sells office supplies) has been delayed. All point to a troubled earnings report. Still, much of the bad news should already be priced in, so don't be surprised if 3M stock rises if management's recommendations and comments turn out not to be so bad. Still, the earnings report is unlikely to do much good for long-term investors who are looking for convincing evidence that the turnaround attempts are working. Thus, 3M is likely to remain a good value stock, but with doubts surrounding it.
NYSE:MMMLong
by FOREXN1
1
MMM: Time for a Technical Breakout 1W (Jun. 09)X Force Global Analysis: 3M (MMM) is a multinational conglomerate corporation operating in the fields of industry, worker safety, US health care, and consumer goods. In this analysis, we take a purely technical approach to the stock, assessing its bullish probabilities. Analysis - What's most noticeable in 3M's weekly chart is the descending parallel channel. - Prices have been creating constant lower highs and lower lows - This downtrend has been intact even before the Corona Virus (Covid-19) situation - Prices are currently trading below the 200 Simple Moving Average (SMA) - They have also been rejected by the Ichimoku cloud resistance twice. - The Relative Strength Index (RSI) is at neutral levels, and the Moving Average Convergence Divergence (MACD) has formed a golden cross, indicating potential bullish momentum - Should we see a breakout from the current price levels through the descending parallel channel, a potential reverse head and shoulders pattern may be intact - There are two price gaps both below and above the current price level, ranging from $!35 to $244. What We Believe For the short term, a break and close above the descending parallel channel is necessary for bullish confirmation. Then, a break of the Ichimoku cloud resistance - which we have failed to break through twice- is required for further bullish confirmation. Ultimately, a break and close above the 200 SMA would confirm a further rally up to $244, where the price gap remains for the weekly chart. Trade Safe.
NYSE:MMM
by XForceGlobal
1